Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesBioventix

Bioventix

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
1990.0 GBX 15.00 ( 0.76%)
Last update at 2026-10-27T16:35:00Z
VOLUME
14688
Market Cap
94.05M
P/E
12.86

Momentum Score

…

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1900.00
Low
2050.00
High
52 Week Price Range
1251.47
Low
2801.53
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
1975.00
Dividend Yield
8.00%
Revenue TTM
12.54M
Revenue Per Share
2.40
Gross Profit TTM
11.59M
Debt / Equity
-
ROE
66.64%
Net Debt
-5.08M
ROCE
87.20%
Diluted EPS TTM
1.40

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 10.10M 10.57M 10.13M 9.28M 8.12M
Net income 7.58M 8.10M 8.37M 7.67M 6.73M
Selling general administrative 2.05M 1.99M 1.77M 1.61M 1.51M
Selling and marketing expenses - 1.02M - - -
Gross profit 11.92M 12.68M 11.99M 11.01M 10.11M
Reconciled depreciation 0.09M 0.11M 0.13M 0.14M 0.14M
Ebit 10.07M 10.63M 10.13M 9.28M 8.38M
Ebitda 10.17M 10.74M 10.26M 9.42M 8.52M
Depreciation and amortization 0.09M 0.11M 0.13M 0.14M 0.14M
Operating income 9.90M 10.60M 10.03M 9.27M 8.09M
Other operating expenses 3.21M 3.02M 2.75M 2.54M 2.55M
Interest expense - - 0.00M 0.00M 0.26M
Tax provision 2.51M 2.51M 1.76M 1.60M 1.39M
Interest income 0.19M 0.20M 0.10M 0.00M 0.03M
Net interest income 0.19M 0.20M 0.10M 0.00M 0.03M
Income tax expense 2.51M 2.48M 1.76M 1.60M 1.39M
Total revenue 13.12M 13.61M 12.82M 11.72M 10.93M
Total operating expenses 2.01M 2.10M 1.92M 1.83M 1.73M
Cost of revenue 1.20M 0.93M 0.83M 0.71M 0.82M
Total other income expense net 0.19M 0.02M 0.10M 0.00M -0.26M
Net income from continuing ops 7.58M 8.10M 8.37M 7.67M 6.73M
Net income applicable to common shares - - - 7.67M 6.73M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 12.86M 13.73M 13.28M 13.12M 12.91M
Other current assets 0.02M 0.00M - 5.22M 4.63M
Total liab 1.31M 1.73M 1.22M 1.30M 1.09M
Total stockholder equity 11.55M 12.00M 12.06M 11.82M 11.82M
Other current liab 0.36M 0.38M 1.12M 1.09M 1.01M
Common stock 0.26M 0.26M 0.26M 0.26M 0.26M
Capital stock 0.26M 0.26M 0.26M 0.26M 0.26M
Retained earnings 9.75M 10.27M 10.33M 10.23M 10.23M
Other liab - - - 0.04M 0.08M
Cash 5.08M 6.00M 5.72M 6.13M 6.49M
Total current liabilities 1.31M 1.73M 1.20M 1.25M 1.01M
Net debt -5.08M -6.00M -5.72M -6.13M -6.49M
Other stockholder equity 1.54M 1.47M 1.47M -10.49M -10.49M
Property plant equipment - - - 0.69M 0.84M
Total current assets 12.03M 12.83M 12.10M 11.81M 11.45M
Net tangible assets - - - 11.82M 11.82M
Net receivables 6.24M 6.21M 1.17M 0.76M 4.63M
Inventory 0.69M 0.62M 0.57M 0.46M 0.33M
Accounts payable 0.08M 0.17M 0.08M 1.25M 1.01M
Accumulated other comprehensive income 0.00M 0.00M - - -
Non currrent assets other - 0.43M 0.61M -1.30M -1.45M
Non current assets total 0.83M 0.90M 1.19M 1.30M 1.45M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 0.17M 0.19M 0.09M -0.01M -0.23M
Change to liabilities - - - 0.08M 0.06M
Total cashflows from investing activities 0.17M 0.19M - -0.01M -0.23M
Total cash from financing activities -8.12M -8.25M -8.30M -7.92M -7.69M
Net income 7.58M 8.10M 8.37M 7.67M 6.73M
Change in cash -0.92M 0.28M -0.41M -0.37M -1.58M
Begin period cash flow 6.00M 5.72M 6.13M 6.49M 8.08M
End period cash flow 5.08M 6.00M 5.72M 6.13M 6.49M
Total cash from operating activities 7.03M 8.34M 7.80M 7.56M 6.34M
Issuance of capital stock 0.07M 0.00M 0.14M 0.00M 0.02M
Depreciation 0.09M 0.11M 0.13M 0.14M 0.14M
Other cashflows from investing activities 0.19M 0.20M - 0.00M 0.03M
Dividends paid 8.19M 8.25M 8.44M 7.92M 7.71M
Change to inventory -0.07M -0.05M -0.10M -0.13M -0.09M
Change to account receivables -0.03M -0.39M - -0.60M -0.98M
Sale purchase of stock - - - - 0.02M
Other cashflows from financing activities - -0.02M 0.09M -0.00M -0.23M
Change to netincome - - - 0.39M 0.47M
Capital expenditures 0.02M 0.02M 0.01M 0.01M 0.26M
Change in working capital -0.21M -0.36M -0.78M -0.65M -1.00M
Stock based compensation 0.09M 0.09M 0.17M 0.24M 0.26M
Other non cash items -0.53M 0.50M -0.10M -0.00M -0.03M
Free cash flow 7.01M 8.33M 7.79M 7.55M 6.08M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BVXP
Bioventix		 15.00
0.76%		 1990.00 12.86 11.39 7.50 7.57 6.24 7.96
GNS
Genus PLC		 18.00
0.78%		 2340.00 36.08 26.18 2.53 3.46 2.92 15.38
ONT
Oxford Nanopore Technologies Ltd		 10.60
4.93%		 225.60 - - 4.71 2.50 4.23 -8.89
OXB
Oxford BioMedica PLC		 5.00
0.95%		 532.00 - 208.33 4.05 7.60 4.42 308.96
AVCT
Avacta Group PLC		 -1.00
1.60%		 61.50 - - 2849.46 1929.84 2525.51 -12.04

Profile*

Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

7 Romans Business Park, Farnham, United Kingdom, GU9 7SX

44 12 5272 8001

https://www.bioventix.com

12

Name Title Year Born
Mr. Peter John Harrison MA CEO & Director 1958
Mr. Bruce Edward Heath Hiscock CFO & Director 1958

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…